This article refers to:
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials
This article is referred to by:
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials: Response to Commentaries
What Lies Beneath the Framework: The Importance of Grounding Ethical Discussions of Maternal-Fetal Therapy
Fetal Therapies and Clinical Research: Beyond Risk and Benefit

DISCLOSURE STATEMENT

Professor Jan Deprest is a strategic board member of Vitara Biomed, Inc, Philadelphia.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.